Profile data is unavailable for this security.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OssDsign AB | 117.72m | -118.39m | 908.23m | 48.00 | -- | 4.05 | -- | 7.72 | -1.51 | -1.51 | 1.40 | 2.30 | 0.3907 | 3.60 | 6.62 | 2,452,500.00 | -39.29 | -37.92 | -43.39 | -43.56 | 77.15 | 68.10 | -100.57 | -203.06 | 5.18 | -36.90 | 0.013 | -- | 96.84 | 53.26 | -31.30 | -- | -56.16 | -- |
Nightingale Health Oyj | 41.36m | -204.40m | 920.00m | 81.00 | -- | 1.36 | -- | 22.24 | -0.2979 | -0.2979 | 0.0603 | 1.50 | 0.0344 | 1.60 | 3.87 | 44,560.98 | -17.02 | -14.20 | -18.12 | -15.69 | 75.81 | 83.57 | -494.25 | -408.50 | 14.15 | -- | 0.0378 | -- | 80.80 | 19.05 | -12.38 | -- | -- | -- |
Paxman AB (publ) | 226.42m | 23.97m | 977.24m | 94.00 | 40.85 | 7.18 | 22.96 | 4.32 | 1.26 | 1.26 | 11.89 | 7.16 | 1.28 | 2.66 | 6.46 | 2,488,099.00 | 13.59 | -5.08 | 18.38 | -7.76 | 69.47 | 69.38 | 10.59 | -5.07 | 1.76 | -- | 0.1122 | -- | 43.99 | 29.35 | 180.69 | -- | 6.26 | -- |
Integrum AB | 104.12m | 4.17m | 1.08bn | 36.00 | 261.09 | 7.06 | 169.84 | 10.34 | 0.2199 | 0.2199 | 5.55 | 8.13 | 0.6307 | 0.5919 | 3.80 | 2,892,222.00 | 2.53 | 0.7612 | 2.80 | 0.8818 | 87.65 | 83.87 | 4.01 | 1.28 | 3.32 | -- | 0.043 | -- | 40.19 | 35.91 | 212.14 | -- | 127.10 | -- |
SyntheticMR AB (publ) | 90.86m | 15.67m | 1.15bn | 38.00 | 72.82 | 9.61 | 52.25 | 12.71 | 0.3804 | 0.3804 | 2.21 | 2.88 | 0.6719 | -- | 1.58 | 2,455,541.00 | 11.59 | 7.19 | 13.87 | 8.85 | 73.94 | 69.70 | 17.25 | 9.08 | -- | -- | 0.0083 | 21.50 | 30.67 | 13.05 | 70.34 | -7.33 | 27.30 | -- |
Optomed Oyj | 169.20m | -49.50m | 1.31bn | 114.00 | -- | 5.44 | -- | 7.72 | -0.2575 | -0.2575 | 0.8872 | 1.08 | 0.5199 | 1.70 | 3.94 | 131,131.60 | -15.21 | -12.95 | -18.59 | -15.90 | 66.76 | 65.69 | -29.25 | -27.84 | 1.72 | -12.96 | 0.1894 | -- | 3.00 | 3.47 | 18.84 | -- | 7.26 | -- |
BioPorto A/S | 49.14m | -81.68m | 1.40bn | 27.00 | -- | 19.57 | -- | 28.53 | -0.1501 | -0.1501 | 0.0903 | 0.1099 | 0.4132 | 3.66 | 7.33 | 1,044,452.00 | -68.68 | -71.10 | -100.20 | -96.55 | 68.08 | 63.38 | -166.23 | -239.22 | 2.36 | -- | 0.1354 | -- | 6.87 | 3.54 | 25.81 | -- | -51.56 | -- |
Nordhealth As | 419.50m | -126.82m | 1.42bn | 395.00 | -- | 2.64 | -- | 3.39 | -1.62 | -1.62 | 5.34 | 12.00 | 0.3561 | -- | 8.25 | 1,068,542.00 | -10.76 | -- | -12.25 | -- | 85.96 | -- | -30.23 | -- | -- | -- | 0.00 | -- | 18.60 | -- | 21.96 | -- | -- | -- |
C Rad AB | 458.22m | 48.23m | 1.43bn | 89.00 | 30.48 | 5.06 | 24.93 | 3.13 | 1.43 | 1.43 | 13.57 | 8.61 | 1.20 | 4.90 | 3.05 | 5,266,839.00 | 12.69 | 5.09 | 17.96 | 7.02 | 45.14 | 43.12 | 10.61 | 4.86 | 2.43 | -- | 0.0058 | 0.00 | 40.92 | 17.44 | 375.05 | 10.89 | 33.69 | -- |
ADDvise Group AB (publ) | 1.48bn | 110.80m | 1.47bn | 620.00 | 26.60 | 3.72 | 6.53 | 0.9926 | 0.5864 | 0.5864 | 7.84 | 4.20 | 0.5506 | 6.73 | 5.52 | 2,365,224.00 | 4.14 | 3.72 | 5.17 | 4.77 | 47.63 | 48.95 | 7.51 | 5.89 | 1.09 | 2.99 | 0.6608 | 0.9405 | 44.30 | 38.62 | 27.62 | -- | 30.35 | -- |
Genovis AB | 127.01m | 30.68m | 1.76bn | 36.00 | 57.51 | 8.60 | 42.57 | 13.89 | 0.4686 | 0.4686 | 1.94 | 3.13 | 0.5084 | -- | -- | 3,432,784.00 | 12.28 | 18.56 | 13.37 | 21.45 | 66.09 | 65.51 | 24.15 | 23.88 | -- | -- | 0.2769 | 0.00 | 54.54 | 35.56 | 449.56 | -- | 47.59 | -- |
Stille AB | 362.16m | 35.58m | 1.93bn | 142.00 | 35.83 | 2.99 | 36.22 | 5.33 | 6.00 | 6.00 | 60.20 | 71.84 | 0.5364 | 1.77 | 7.18 | 3,416,557.00 | 5.27 | 7.03 | 6.35 | 8.19 | 46.76 | 43.93 | 9.82 | 9.85 | 0.9879 | 7.17 | 0.00 | 21.98 | 19.70 | 16.78 | -2.48 | 5.34 | 23.62 | -- |
Bactiguard Holding AB | 220.81m | -126.19m | 2.18bn | 191.00 | -- | 7.16 | -- | 9.87 | -3.60 | -3.60 | 6.30 | 9.80 | 0.3035 | 4.28 | 6.00 | 1,017,544.00 | -17.35 | -7.56 | -19.82 | -8.81 | 29.87 | 47.91 | -57.15 | -26.28 | 1.64 | -11.90 | 0.4129 | -- | -11.96 | 6.46 | -161.71 | -- | 8.43 | -- |
Sedana Medical AB (publ) | 164.91m | -22.83m | 2.26bn | 83.00 | -- | 2.29 | 33,307.10 | 13.73 | -0.2299 | -0.2299 | 1.66 | 9.95 | 0.1564 | 1.24 | 8.10 | 2,087,443.00 | -2.17 | -5.77 | -2.28 | -6.08 | 70.50 | 64.06 | -13.85 | -36.13 | 7.38 | -- | 0.0043 | -- | 25.23 | 21.59 | 18.90 | -- | 42.12 | -- |
Data as of Jul 03 2024. Currency figures normalised to Genovis AB's reporting currency: Swedish Krona SEK
35.84%Per cent of shares held by top holders
Holder | Shares | % Held |
---|---|---|
Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 31 May 2023 | 4.88m | 7.45% |
�landsbanken Abp (Private Banking)as of 31 Aug 2023 | 3.66m | 5.60% |
Teknik Innovation Norden Fonder ABas of 31 Aug 2023 | 3.32m | 5.07% |
Swedbank Robur Fonder ABas of 31 May 2024 | 3.10m | 4.74% |
Andra AP-fondenas of 31 Aug 2023 | 2.23m | 3.41% |
Aktia Bank Plc (Investment Management)as of 31 Aug 2023 | 1.88m | 2.87% |
Danske Bank A/S (Investment Management)as of 31 May 2024 | 1.75m | 2.67% |
Handelsbanken Fonder ABas of 31 May 2024 | 1.50m | 2.29% |
Lonvia Capital SASUas of 30 Jun 2023 | 731.48k | 1.12% |
Nordea Investment Management AB (Finland)as of 29 Feb 2024 | 410.42k | 0.63% |
More ▼
Data from 31 Dec 2022 - 31 May 2024Source: FactSet Research Systems Inc.